| Name |
Position |
Presentation (ppt) |
| Sudhir Srivastava, Ph.D., M.P.H. |
Chief, Cancer Biomarkers Research Group |
Metabolomics: An Untapped Frontier (ppt, 161kb) |
| John Milner, Ph.D. |
Chief, Nutritional Sciences Research Group |
Can Metabolomics Provide Clues about the Progression of Disease (ppt, 430kb) |
Padma Maruvada, Ph.D.
Young Kim, Ph.D. |
Program Director, Cancer Biomarkers Research Group Director, Nutritional Sciences Research Group |
Frontiers in Metabolomics for Cancer Research (ppt, 85kb)
Meeting Objectives and Sponsors (ppt, 44kb) |
| Jules Griffin |
University of Cambridge Department of Biochemistry |
What is Metabolomics/Metabonomics (ppt, 3.6mb) |
| Stephen C. Brown |
Research Fellow, Chemistry, Esperion Therapeutics |
Technologies for Metabolics Profiling (ppt, 646kb) |
| Henri Brunengrager |
Case School of Medicine MIT School of Engineering |
Pathway Discovery via the Association of Metabolomics and Mass Isotopomer Analysis (ppt, 645kb) |
| Sybille Mazurek |
Institute of Biochemistry & Endocrinology, Veterinary Faculty, University of Giessen |
A Crossroad to Tumor Metabolome: Pyruvate Kinase Type M2 (ppt, 11.2mb) |
| John Griffiths |
Cancer Research UK Biomedical Magnetic Resonance Research Group, Department of Basic Medical Sciences, St George's Hospital Medical School |
Metabolomics by Magnetic Resonance: From Molecules to Man (ppt, 1.9mb) |
| Leo Cheng |
Massachusetts General Hospital Harvard University |
Metabolomic Profiling of Human Cancer With Ex Vivo Tissue MR Spectroscopy (ppt, 38mb) |
| Paul Lee, M.D. |
David Geffen School of Medicine at UCLA - Los Angeles Biomedical Research Institute at Harbor-UCLA |
Glucose Metabolics Phenotypes in Cancer (ppt, 983kb) |
| Edward A. Dennis |
Departments of Pharmacology and Chemistry/Biochemistry University of California, San Diego |
Lipidomic Profiling Eicosanoid Changes in Carcinogenesis (ppt, 7.6mb) |
| Risto A. Kauppien |
University of Birmingham, U.K. |
MR Spectroscopic Analysis of Tumour Metabolic Phenotype Changes in Response to Therapy (ppt, 21.9mb) |
| Zoltan N. Oltvai |
Department of Pathology University of Pittsburgh School of Medicine |
Other models to understand the cancer cell metabolic flux (ppt, 12.5mb) |
| Rima Kaddurah-Daouk,Ph.D. |
Duke University Medical Center |
Metabolomics in the study of CNS Disorders: Early Lessons Learned (ppt, 5.9mb) |
| Michael N. Liebman, Ph.D. |
Executive Director Windber Research Institute |
A Systems Approach to Breast Cancer (ppt, 2.1mb) |
| Bruce Kristal and Gilbert Omenn |
|
Application of Metabolomics in Understanding Tumor Cell Behavior (ppt, 28kb) |
Young Kim, Ph.D.
Padma Maruvada, Ph.D. |
Director, Nutritional Sciences Research Group Program Director, Cancer Biomarkers Research Group |
Future Directions (ppt, 44kb)
Thank You (ppt, 42kb) |
